Protein L-isoaspartyl methyltransferase regulates p53 activity

Nature Communications

Volumn 3, Issue , 2012, Pages

  Lee, Jae Cheol ^a   Kang, Sung Ung ^b   Jeon, Yeji ^a   Park, Jong Woo ^a   You, Jueng Soo ^a   Ha, Shin Won ^a   Bae, Narkhyun ^b   Lubec, Gert ^b   Kwon, So Hee ^c   Lee, Ju Seog ^d   Cho, Eun Jung ^a   Han, Jeung Whan ^a  

^a Sungkyunkwan University   (South Korea)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c Yonsei University   (South Korea)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ISOASPARTIC ACID; PROTEIN LEVO ISOASPARTYL METHYLTRANSFERASE; PROTEIN MDM2; PROTEIN METHYLTRANSFERASE; PROTEIN P53; UNCLASSIFIED DRUG; PROTEIN DEXTRO ASPARTATE METHYLTRANSFERASE;

APOPTOSIS; ARTICLE; CANCER CELL; CONTROLLED STUDY; ENZYME ACTIVITY; GENE TARGETING; HUMAN; HUMAN CELL; IN VITRO STUDY; MEDIATOR; PROTEIN BLOOD LEVEL; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN METHYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; RECEPTOR UPREGULATION; TRANSCRIPTION REGULATION; CHROMATIN IMMUNOPRECIPITATION; FLOW CYTOMETRY; GENETICS; IMMUNOBLOTTING; IMMUNOPRECIPITATION; METABOLISM; PROTEIN BINDING; REAL TIME POLYMERASE CHAIN REACTION; TANDEM MASS SPECTROMETRY; TUMOR CELL LINE;

CELL LINE, TUMOR; CHROMATIN IMMUNOPRECIPITATION; FLOW CYTOMETRY; HUMANS; IMMUNOBLOTTING; IMMUNOPRECIPITATION; PROTEIN BINDING; PROTEIN D-ASPARTATE-L-ISOASPARTATE METHYLTRANSFERASE; REAL-TIME POLYMERASE CHAIN REACTION; TANDEM MASS SPECTROMETRY; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84863324605     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms1933     Document Type: Article

References (41)

1. Clarke, S. Aging as war between chemical and biochemical processes: protein methylation and the recognition of age-damaged proteins for repair. Ageing Res. Rev. 2, 263-285 (2003). (Pubitemid 38340316)
2. Weintraub, S. J. & Deverman, B. E. Chronoregulation by asparagine deamidation. Sci. STKE 409, re7 (2007).
3. Reissner, K. J. & Aswad, D. W. Deamidation and isoaspartate formation in proteins: unwanted alterations or surreptitious signals? Cell. Mol. Life Sci. 60, 1281-1295 (2003). (Pubitemid 36900513)
4. Desrosiers, R. R. & Fanélus, I. Damaged proteins bearing L-isoaspartyl residues and aging: a dynamic equilibrium between generation of isomerized forms and repair by PIMT. Curr. Aging Sci. 1, 8-18 (2011).
5. Bidinosti, M. et al. Postnatal deamidation of 4E-BP2 in brain enhances its association with raptor and alters kinetics of excitatory synaptic transmission. Mol. Cell 37, 797-808 (2010).
6. Curnis, F. et al. Spontaneous formation of L-isoaspartate and gain of function in fibronectin. J. Biol. Chem. 281, 36466-36476 (2006). (Pubitemid 46041380)
7. Curnis, F. et al. Isoaspartate-glycine-arginine: a new tumor vasculature-targeting motif. Cancer Res. 68, 7073-7082 (2008).
8. Curnis, F. et al. Critical role of flanking residues in NGR-to-isoDGR transition and CD13/integrin receptor switching. J. Biol. Chem. 285, 9114-9123 (2010).
9. Corti, A. & Curnis, F. Isoaspartate-dependent molecular switches for integrin-ligand recognition. J. Cell Sci. 124, 515-522 (2011).
10. Chavous, D. A., Jackson, F. R. & O'Connor, C. M. Extension of the Drosophila lifespan by overexpression of a protein repair methyltransferase. Proc. Natl. Acad. Sci. USA 98, 14814-14818 (2001). (Pubitemid 34013927)
11. Khare, S., Linster, C. L. & Clarke, S. G. The interplay between protein L-isoaspartyl methyltransferase activity and insulin-like signaling to extend lifespan in Caenorhabditis elegans. PLoS One 6, e20850 (2011).
12. Deverman, B. E. et al. Bcl-xL deamidation is a critical switch in the regulation of the response to DNA damage. Cell 111, 51-62 (2002).
13. Zhao, R. et al. DNA damage-induced Bcl-xL deamidation is mediated by NHE-1 antiport regulated intracellular pH. PLoS Biol. 5, e1 (2007).
14. Zhao, R., Yang, F. T. & Alexander, D. R. An oncogenic tyrosine kinase inhibits DNA repair and DNA-damage-induced Bcl-xL deamidation in T cell transformation. Cancer Cell 5, 37-49 (2004). (Pubitemid 38121595)
15. Zhao, R. et al. Inhibition of the Bcl-xL deamidation pathway in myeloproliferative disorders. N. Engl. J. Med. 359, 2778-2789 (2008).
16. Cimmino, A. et al. Protein isoaspartate methyltransferase prevents apoptosis induced by oxidative stress in endothelial cells: role of Bcl-Xl deamidation and methylation. PLoS One 3, e3258 (2008).
17. Huebscher, K. J. et al. Protein isoaspartyl methyltransferase protects from Bax-induced apoptosis. Gene 240, 333-341 (1999).
18. Lee, S. H. & Cho, Y. D. Induction of apoptosis in leukemia U937 cells by 5?-deoxy-5?-methylthioadenosine, a potent inhibitor of protein carboxyl-methyltransferase. Exp. Cell Res. 240, 282-292 (1998). (Pubitemid 28371109)
19. Sambri, I. et al. The microRNA 15a/16-1 cluster down-regulates protein repair isoaspartyl methyltransferase in hepatoma cells: implications for apoptosis regulation. J. Biol. Chem. 286, 43690-43700 (2011).
20. Meek, D. W. & Anderson, C. W. Posttranslational modification of p53: cooperative integrators of function. Cold Spring Harb. Perspect. Biol. 1, a000950 (2009).
21. Chuikov, S. et al. Regulation of p53 activity through lysine methylation. Nature 432, 353-360 (2004). (Pubitemid 39551664)
22. Huang, J. et al. Repression of p53 activity by Smyd2-mediated methylation. Nature 444, 629-632 (2006). (Pubitemid 44864441)
23. Shi, X. et al. Modulation of p53 function by SET8-mediated methylation at lysine 382. Mol. Cell 27, 636-646 (2007). (Pubitemid 47238634)
24. Huang, J. et al. p53 is regulated by the lysine demethylase LSD1. Nature 449, 105-108 (2007). (Pubitemid 47373772)
25. Jansson, M. et al. Arginine methylation regulates the p53 response. Nat. Cell Biol. 10, 1431-1439 (2008).
26. Huang, J. et al. G9a and Glp methylate lysine 373 in the tumor suppressor p53. J. Biol. Chem. 285, 9636-9641 (2010).
27. Director's Challenge Consortium for the Molecular Classification of Lung Adenocarcinoma et al. Gene expression-based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study. Nat. Med. 14, 822-827 (2008).
28. Miller, L. D. et al. An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival. Proc. Natl. Acad. Sci. USA 102, 13550-13555 (2005). (Pubitemid 41420886)
29. Ivshina, A. V. et al. Genetic reclassification of histologic grade delineates new clinical subtypes of breast cancer. Cancer Res. 66, 10292-10301 (2006). (Pubitemid 44799747)
30. Ingrosso, D., Fowler, A. V., Bleibaum, J. & Clarke, S. Sequence of the D-aspartyl/L-isoaspartyl protein methyltransferase from human erythrocytes. Common sequence motifs for protein, DNA, RNA, and small molecule S-adenosylmethionine-dependent methyltransferases. J. Biol. Chem. 264, 20131-20139 (1989). (Pubitemid 20008135)
31. Kagan, R. M. & Clarke, S. Widespread occurrence of three sequence motifs in diverse S-adenosylmethionine-dependent methyltransferases suggests a common structure for these enzymes. Arch. Biochem. Biophys. 310, 417-427 (1994).
32. Corti, A. & Curnis, F. Isoaspartate-dependent molecular switches for integrin-ligand recognition. J. Cell. Sci. 124, 515-522 (2011).
33. Geiger, T. & Clarke, S. Deamidation, isomerization, and racemization at asparaginyl and aspartyl residues in peptides. Succinimide-linked reactions that contribute to protein degradation. J. Biol. Chem. 262, 785-794 (1987). (Pubitemid 17005254)
34. Ota, I. M. & Clarke, S. Enzymatic methylation of L-isoaspartyl residues derived from aspartyl residues in affinity-purified calmodulin. The role of conformational flexibility in spontaneous isoaspartyl formation. J. Biol. Chem. 264, 54-60 (1989). (Pubitemid 19027574)
35. Robinson, N. A. & Robinson, A. B. Deamidation of human proteins. Proc. Natl. Acad. Sci. USA 98, 12409-12413 (2001). (Pubitemid 33019959)
36. Robinson, N. E. Protein deamidation. Proc. Natl. Acad. Sci. USA 99, 5283-5288 (2002). (Pubitemid 34411540)
37. Robinson, N. E. & Robinson, A. B. Amide molecular clocks in drosophila proteins: potential regulators of aging and other processes. Mech. Ageing Dev. 125, 259-267 (2004). (Pubitemid 38438504)
38. el-Deiry, W. S. et al. WAF1, a potential mediator of p53 tumor suppression. Cell 75, 817-825 (1993). (Pubitemid 23346378)
39. Kim, Y. K. et al. Activation of NF-kappaB by HDAC inhibitor apicidin through Sp1-dependent de novo protein synthesis: its implication for resistance to apoptosis. Cell Death Differ. 13, 2033-2041 (2006). (Pubitemid 44742686)
40. Vander Haar, E. et al. Insulin signalling to mTOR mediated by the Akt/PKB substrate PRAS40. Nat. Cell Biol. 9, 316-323 (2007).
41. Kang, S. U., Heo, S. & Lubec, G. Mass spectrometric analysis of GABAA receptor subtypes and phosphorylations from mouse hippocampus. Proteomics 11, 2171-2181 (2011).